ArticleOncology letters2018
PLAC1-specific TCR-engineered T cells mediate antigen-specific antitumor effects in breast cancer.
Qiongshu Li et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
18 papers cite it
this paperpooled itcites it